Lion’s Potenzone Signs on to Plan Strategy at Ingenuity | GenomeWeb

After nearly a year of trying to spin out a company based on an ADME/tox prediction technology from Lion Bioscience, Rudy Potenzone raised the white flag and looked for another opportunity. That came in the form of Ingenuity Systems, a pathway analysis company based in Mountain View, Calif., where Potenzone began in March as the new senior vice president of business development and strategic planning.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.